Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix to Provide Karolinska Institutet with Technology for Disease Studies

NEW YORK, Feb. 8 (GenomeWeb News) - The Karolinska Institutet of Swedenhas teamed up with Affymetrix to study gene expression and DNA sequence variation in patients with a number of diseases, the two partners said today.

 

The agreement is part of Affy's translational medicine initiative. Karolinska Institutet, based in Stockholm, will have early access to new microarray technologies from Affymetrix, including the company's Mapping 100K array for high-density genome scans, and will be able to perform studies "at an acceptable cost," according to Jan Carlstedt-Duke, Karolinska's dean of research.

 

Further financial details of the alliance were not provided.

 

Over the next five years, Karolinska researchers plan to study gene expression and genetic variation in patients with atherosclerosis, breast cancer, rheumatoid arthritis, asthma, and dyslexia.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.